Why This Book Exists

Why This Book Exists

If you are reading this, chances are that you or someone you love has been diagnosed with prostate cancer — or is worried about it. You may be overwhelmed. You may be confused by medical terms, conflicting opinions, and an ocean of information online. You may not know where to start.

This book was written by a radiation oncologist — a cancer doctor who specializes in using radiation to treat cancer. Most patient books about prostate cancer are written by urologists (surgeons) or medical oncologists (chemotherapy doctors). There is nothing wrong with that, but it means that one of the three major perspectives in prostate cancer care — radiation therapy — has been underrepresented in patient education. This book aims to fill that gap, while covering the full picture: surgery, radiation, medications, and everything in between.

This is not a textbook. It is a guide — written in plain language, for real people, about a disease that affects millions of men and their families around the world.

What You Will Learn

This book walks you through the entire prostate cancer journey:

• Understanding your body — what the prostate is, what it does, and what can go wrong
• Understanding your cancer — what prostate cancer is, how it is found, how it is graded and staged
• Understanding your options — surgery, radiation, medications, active surveillance, clinical trials, and more
• Living with and beyond cancer — managing side effects, emotional health, diet, exercise, finances, and survivorship

By the end, you will not be a doctor — but you will be a more informed, more confident, more empowered patient. And that matters enormously.

How to Read This Book

You do not have to read this book from cover to cover.

Think of it as a reference guide. If you were just diagnosed, start with Chapters 1 through 6 to understand your cancer. If you are deciding between treatments, jump to Section II. If you are already in treatment and dealing with side effects, go straight to Section III. If a family member handed you this book and you just want the basics, read the "Key Takeaways" boxes at the end of each chapter.

Every chapter follows the same structure so you always know what to expect:

1. A patient story to set the scene (fictional composites, clearly labeled)
2. The main content — medical information explained simply
3. Illustrations — diagrams and visuals to help you see what we are describing
4. "Myth vs. Fact" — common misconceptions corrected
5. "Questions to Ask Your Doctor" — so you walk into your next appointment prepared
6. Key Takeaways — a quick summary of the most important points
7. Support Resources — where to go for more help

No Two Cancers Are the Same

One of the most important things to understand from the very beginning is this: no two prostate cancers are exactly alike, and no two patients are exactly alike.

Your neighbor may have had prostate cancer and been fine with no treatment. Your uncle may have had prostate cancer and needed surgery and radiation. A man in your support group may be on hormone therapy. None of their stories is your story.

Your cancer has its own grade, its own stage, its own biology. Your body has its own health history, its own strengths, its own vulnerabilities. Your life has its own priorities, values, and goals. The "right" treatment for you depends on all of these factors — not just what worked for someone else.

This is why shared decision-making is so important. The best treatment decisions happen when you and your doctors work together — when the medical team explains the options honestly, and you share your preferences, your concerns, and what matters most to you.^[1][2] Research shows that patients who participate in shared decision-making are more knowledgeable, have more realistic expectations, and make choices that better align with their personal values.^[3][4]

No single doctor has all the answers. That is why many cancer centers use multidisciplinary teams — a urologist, a radiation oncologist, a medical oncologist, a pathologist, and others — who review your case together. If your center does not offer this, it is perfectly reasonable to seek opinions from more than one specialist. In fact, it is encouraged.

A Word About Evidence in Medicine

Throughout this book, you will see us refer to "evidence" and "studies." It is worth taking a moment to explain what that means — because not all evidence is created equal.

What is evidence-based medicine?

Evidence-based medicine means that the recommendations your doctors make are based on the best available scientific research — not just personal opinion or tradition. Doctors combine the research evidence with their clinical experience and your personal preferences to make decisions.^[5]

How strong is the evidence?

Medical evidence exists on a spectrum. At the top are randomized controlled trials (RCTs) — studies where patients are randomly assigned to different treatments, and the results are compared. These are considered the gold standard because they minimize bias. Even stronger are meta-analyses — studies that combine the results of multiple RCTs to get a bigger, clearer picture.^[6][7][8]

Below RCTs are observational studies — where researchers watch what happens to patients without assigning treatments. These can be useful but are more prone to bias. At the bottom are case reports (stories about individual patients) and expert opinion.

Here is a simplified way to think about it:

What are clinical practice guidelines?

Guidelines are documents created by panels of experts who review all the available evidence and translate it into practical recommendations for doctors.^[6][5] The most widely used guidelines in prostate cancer come from:

• NCCN (National Comprehensive Cancer Network) — used by most cancer centers in the United States
• AUA (American Urological Association)
• EAU (European Association of Urology)
• ACS (American Cancer Society)

These guidelines are updated regularly as new evidence emerges. They are not laws — they are frameworks to help doctors and patients make informed decisions. Sometimes guidelines from different organizations disagree with each other. When that happens, it does not mean one is right and the other is wrong — it often means the evidence is not yet clear enough for everyone to agree.

Why does this matter to you?

Because when you read something online, hear something from a friend, or see a headline that says "New cure for prostate cancer!" — you now have a framework to ask: How strong is the evidence behind this claim? A single small study is not the same as a large randomized trial. A blog post is not the same as a clinical guideline. A testimonial is not the same as scientific proof.

Understanding Bias

Bias is a word you will encounter throughout medicine, and it does not mean what it means in everyday conversation. In research, bias means a systematic error that can push results away from the truth.^[9][10]

There are many types of bias, but here are the ones most relevant to you as a patient:

• Selection bias — when the patients chosen for a study are not representative of all patients. For example, if a study only includes very healthy men, the results may not apply to men with other health problems.^[9][10]
• Lead-time bias — this is especially important in screening. If a cancer is found earlier through screening, the patient appears to survive longer — but only because the clock started ticking sooner, not because the patient actually lived longer. This can make screening look more beneficial than it truly is.^[11]
• Publication bias — studies with positive or exciting results are more likely to be published than studies that find no effect. This means the medical literature can paint an overly optimistic picture of certain treatments.^[10][12]
• Confirmation bias — the tendency to pay attention to information that supports what you already believe and ignore information that contradicts it. This affects patients, doctors, and researchers alike.
• Commercial bias — some information, especially online, is created or funded by companies that sell treatments, supplements, or devices. The information may be accurate, but it may also be selectively presented to make a product look better than it is.

Why does this matter to you?

Because understanding bias helps you become a smarter consumer of medical information. When you read a study or a news article, ask yourself:

• Who paid for this research?
• How many patients were included?
• Were the patients similar to me?
• Was this a randomized trial or an observational study?
• Has this been confirmed by other studies?

You do not need to become a scientist. But a little healthy skepticism goes a long way.

Navigating Information in the Internet Age

We live in an era of information overload. A single internet search for "prostate cancer" returns millions of results. Social media is filled with stories, advice, and claims — some helpful, some misleading, and some outright dangerous.

Research shows that approximately 27% of cancer-related content on social media contains misinformation, and about 21% contains potentially harmful information.^[13] Cancer misinformation ranges from inaccurate information about risk factors to unproven treatments to conspiracy theories.^[14] Inaccurate posts often receive more engagement (likes, shares, views) than accurate ones.^[14]

This does not mean you should avoid the internet. It means you should be selective:

Trustworthy sources include:

• Your own medical team
• National Cancer Institute (cancer.gov)
• NCCN patient guidelines (nccn.org)
• Prostate Cancer Foundation (pcf.org)
• ZERO Prostate Cancer (zerocancer.org)
• American Cancer Society (cancer.org)
• Peer-reviewed medical journals (though these can be technical)

Be cautious with:

• Social media posts and videos (even from doctors — check their credentials and whether they cite evidence)
• Testimonials and anecdotes ("This cured my cancer!")
• Websites selling products or treatments
• News headlines (which often oversimplify or sensationalize research findings)^[15]

When in doubt, bring the information to your doctor and ask: "I read this — is it true? Does it apply to me?" A good doctor will never be offended by that question.

A Note About This Book's Limitations

This book is a guide, not a substitute for your medical team. Medicine is complex, and your situation is unique. The information here is based on the best available evidence at the time of writing, but medical knowledge evolves constantly. New studies are published, guidelines are updated, and new treatments emerge.

Each chapter in this book could easily be expanded into its own book — and in future editions, some of them will be. For now, the goal is to give you a solid foundation: enough knowledge to understand your diagnosis, ask the right questions, and participate meaningfully in your care.

Finally, this book exists in two editions — English and Arabic — because prostate cancer does not respect language barriers, and every patient deserves access to clear, accurate information in a language they understand.

Myth vs. Fact

Myth: "There is one right answer for every prostate cancer patient."

Fact: Treatment is highly personalized. The best choice depends on your cancer's characteristics, your overall health, your life expectancy, your baseline function, and your personal values and preferences. Two men with the same Gleason score may make completely different — and equally valid — treatment decisions.

Myth: "If my doctor recommends something, I should just do it without asking questions."

Fact: The best outcomes happen when patients and doctors make decisions together. Asking questions is not a sign of distrust — it is a sign of engagement. Your doctor should welcome your questions and respect your preferences.^[1][2]

Myth: "Everything I read on the internet about cancer is unreliable."

Fact: There is excellent information available online — but there is also a great deal of misinformation. The key is knowing where to look and how to evaluate what you find.^[14][13]

Key Takeaways

• This book is your companion from diagnosis through survivorship — written by a radiation oncologist to fill a gap in patient education
• No two cancers are the same — your journey is unique, and your treatment should be personalized
• Evidence-based medicine guides the recommendations in this book — not opinion, not tradition, not marketing
• You don't need to read every chapter — start where you need help most and use the consistent chapter structure to find what you need quickly
• Knowledge is power — understanding your cancer, your options, and how to evaluate information helps you make better decisions and advocate for yourself

Support Resources

• National Cancer Institute — cancer.gov — comprehensive, evidence-based cancer information
• NCCN Patient Guidelines — nccn.org/patients — simplified versions of the guidelines doctors use
• Prostate Cancer Foundation — pcf.org — education, research updates, and support
• ZERO Prostate Cancer — zerocancer.org — advocacy, support groups, and patient resources
• American Cancer Society — cancer.org — general cancer information and support services
• Us TOO International — ustoo.org — peer-to-peer support and education

References

1. Clinically Localized Prostate Cancer: AUA/ASTRO Guideline, Part I: Introduction, Risk Assessment, Staging, and Risk-Based Management. Eastham JA, Auffenberg GB, Barocas DA, et al. The Journal of Urology. 2022;208(1):10-18. doi:10.1097/JU.0000000000002757.
2. Prostate Cancer. National Comprehensive Cancer Network. Updated 2026-01-23.
3. Shared Decision Making and Use of Decision Aids for Localized Prostate Cancer : Perceptions From Radiation Oncologists and Urologists. Wang EH, Gross CP, Tilburt JC, et al. JAMA Internal Medicine. 2015;175(5):792-9. doi:10.1001/jamainternmed.2015.63.
4. The Diagnosis and Treatment of Prostate Cancer: A Review. Litwin MS, Tan HJ. JAMA. 2017;317(24):2532-2542. doi:10.1001/jama.2017.7248.
5. How to Interpret and Use a Clinical Practice Guideline or Recommendation: Users’ Guides to the Medical Literature. Brignardello-Petersen R, Carrasco-Labra A, Guyatt GH. JAMA. 2021;326(15):1516-1523. doi:10.1001/jama.2021.15319.
6. Clinical Practice Guidelines Methodology. Melissa B. Weimer DO MCR DFASAM, Emily Brunner MD DFASAM, Devan Kansagara MD, et al. American Society of Addiction Medicine (2023).
7. Further Evolution of the ACC/AHA Clinical Practice Guideline Recommendation Classification System: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Halperin JL, Levine GN, Al-Khatib SM, et al. Journal of the American College of Cardiology. 2016;67(13):1572-1574. doi:10.1016/j.jacc.2015.09.001.
8. 2024 Revision of the Level of Evidence Grading System for ESC Clinical Practice Guideline Recommendations I: Therapy and Prevention. Jüni P, Antoniou S, Arbelo E, et al. European Heart Journal. 2025;46(20):1885-1894. doi:10.1093/eurheartj/ehaf009.
9. Bias and Causal Associations in Observational Research. Grimes DA, Schulz KF. Lancet (London, England). 2002;359(9302):248-52. doi:10.1016/S0140-6736(02)07451-2.
10. Bias in Clinical Research. Tripepi G, Jager KJ, Dekker FW, Wanner C, Zoccali C. Kidney International. 2008;73(2):148-53. doi:10.1038/sj.ki.5002648.
11. Understanding and Identifying Bias and Confounding in the Medical Literature. Hsu JL, Banerjee D, Kuschner WG. Southern Medical Journal. 2008;101(12):1240-5. doi:10.1097/SMJ.0b013e31818860c0.
12. Science Mapping Analysis Characterizes 235 Biases in Biomedical Research. Chavalarias D, Ioannidis JP. Journal of Clinical Epidemiology. 2010;63(11):1205-15. doi:10.1016/j.jclinepi.2009.12.011.
13. Quality of Cancer-Related Information on New Media (2014-2023): Systematic Review and Meta-Analysis. Liu XJ, Valdez D, Parker MA, Mai A, Walsh-Buhi ER. Journal of Medical Internet Research. 2025;27:e73185. doi:10.2196/73185.
14. Cancer Misinformation on Social Media. Loeb S, Langford AT, Bragg MA, Sherman R, Chan JM. CA: A Cancer Journal for Clinicians. 2024 Sep-Oct;74(5):453-464. doi:10.3322/caac.21857.
15. Cancer in the News: Bias and Quality in Media Reporting of Cancer Research. Amberg A, Saunders DN. PloS One. 2020;15(11):e0242133. doi:10.1371/journal.pone.0242133.